AVRICORE HEALTH INC. Research and Development Expense
AVRICORE HEALTH INC. reported Research and Development Expense of CAD 251.51 thousand for the 12-month period ending 2018-12-31, per its 20-F filed 2019-06-17.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2019-06-17
| Period end | Research And Development Expense 6 month | Research And Development Expense 12 month |
|---|---|---|
| 2018-12-31 | 251.51K CAD 20-F · filed 2019-06-17 | |
| 2017-12-31 | 242.30K CAD 20-F · filed 2019-06-17 | |
| 2016-12-31 | 208.78K CAD 20-F · filed 2019-06-17 | |
| 2015-12-31 | 930.00 CAD 20-F · filed 2018-06-19 | |
| 2015-06-30 | 56.14K CAD 20-F · filed 2018-06-19 |